Status:
COMPLETED
Enhanced Recovery After Surgery Protocols in Total Knee Arthroplasty Via Midvastus Approach
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University
Conditions:
ERAS
Knee Osteoarthritis
Eligibility:
All Genders
56-74 years
Phase:
NA
Brief Summary
The study aimed to investigate the impact of enhanced recovery after surgery (ERAS) protocols on the clinical effect of total knee arthroplasty (TKA) via the midvastus approach
Detailed Description
In this study, a randomized controlled study was conducted to further investigate the impact of ERAS protocols in the clinical efficacy of TKA with the midvastus approach. The ERAS protocols were adop...
Eligibility Criteria
Inclusion
- Unilateral primary knee osteoarthritis
- Varus, valgus, and flexion contracture deformity of the knee joint \< 10°
- The range of motion of the knee joint was \> 80°
- Body mass index (BMI) \< 30
- No previous history of knee surgery on the affected side .Agreed to participate in the trial.
Exclusion
- Rheumatoid arthritis
- Extra-knee deformity
- Simultaneous bilateral knee arthroplasty
- Severe dysfunction of the liver, kidney, and blood system
- Severe cardiovascular diseases
- Gastrointestinal ulcer .Other medical conditions like nausea, vomiting, snoring, and allergy to related analgesic drugs.
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT04873544
Start Date
October 1 2018
End Date
June 30 2020
Last Update
May 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanjing first hospital
Nanjing, Jiangsu, China, 210029